首页 > 最新文献

Chinese Medical Sciences Journal最新文献

英文 中文
A Dataset on the Dynamic Monitoring of Health and Family Planning of China’s Internal Migrants: A Multi-Wave Large-Scale, National Cross-Sectional Survey from 2009 to 2018 【中国境内流动人口健康和计划生育动态监测数据集:2009年至2018年多波大规模全国横断面调查】。
Q2 Medicine Pub Date : 2023-09-01 DOI: 10.24920/004254
Sheng-Fa Zhang , Wei Luo , Zhi-Li Wang , Jing Chen , Fang Zhou , Jing-Wen Sun , Jia-Yang Wang , Jing-Chen Zhang , Wei Zhou

This data article presents data from the China Migrants Dynamic Survey (CMDS), a multi-wave, large-scale national cross-sectional survey of China’s internal migrants from 2009 to 2018. The CMDS is an annual questionnaire survey conducted by the former National Health and Family Planning Commission (NHFPC) of the People’s Republic of China. The respondents included in this survey are internal migrants over IS years old. The sample was drawn from the China Migrant Population Information System, using multi-stage stratified sampling method and the probability proportional-to-size (PPS) cluster sampling strategy. Between 2009 and 2018, there were 1,527,650 internal migrants from 23 provinces, 5 autonomous regions and 4 municipalities participated in the surveys. The survey tools were a series of self-designed questionnaires with high inheritance and consistency designed and implemented by the NHFPC. The questionnaires mainly contain basic information of the respondents and their family members, migration status, healthcare or health behaviors, public health service utilization, social insurance, social integration, and family planning. The dataset is currently the most widely used survey data on China’s internal migrants, offering information on migration patterns, healthcare and health behaviors, use of public health services, access to social security, social integration, and family planning, which are valuable for health planning, health decision-making, and health equity research.

这篇数据文章介绍了中国移民动态调查(CMDS)的数据,这是一项针对2009年至2018年中国国内移民的多波大规模全国性横断面调查。CMDS是由中华人民共和国前国家卫生和计划生育委员会(NHFPC)进行的年度问卷调查。本次调查的受访者是15岁以上的国内移民。样本来源于中国流动人口信息系统,采用多阶段分层抽样方法和PPS整群抽样策略。2009年至2018年间,共有来自23个省、5个自治区和4个直辖市的1527650名境内移民参加了调查。调查工具是由NHFPC设计和实施的一系列自行设计的具有高度继承性和一致性的问卷。调查问卷主要包括受访者及其家庭成员的基本信息、移民状况、医疗保健或健康行为、公共卫生服务利用、社会保险、社会融合和计划生育。该数据集是目前使用最广泛的中国境内移民调查数据,提供了移民模式、医疗保健和健康行为、公共卫生服务使用、社会保障、社会融合和计划生育等信息,对健康规划、健康决策和健康公平研究有价值。
{"title":"A Dataset on the Dynamic Monitoring of Health and Family Planning of China’s Internal Migrants: A Multi-Wave Large-Scale, National Cross-Sectional Survey from 2009 to 2018","authors":"Sheng-Fa Zhang ,&nbsp;Wei Luo ,&nbsp;Zhi-Li Wang ,&nbsp;Jing Chen ,&nbsp;Fang Zhou ,&nbsp;Jing-Wen Sun ,&nbsp;Jia-Yang Wang ,&nbsp;Jing-Chen Zhang ,&nbsp;Wei Zhou","doi":"10.24920/004254","DOIUrl":"10.24920/004254","url":null,"abstract":"<div><p>This data article presents data from the China Migrants Dynamic Survey (CMDS), a multi-wave, large-scale national cross-sectional survey of China’s internal migrants from 2009 to 2018. The CMDS is an annual questionnaire survey conducted by the former National Health and Family Planning Commission (NHFPC) of the People’s Republic of China. The respondents included in this survey are internal migrants over IS years old. The sample was drawn from the China Migrant Population Information System, using multi-stage stratified sampling method and the probability proportional-to-size (PPS) cluster sampling strategy. Between 2009 and 2018, there were 1,527,650 internal migrants from 23 provinces, 5 autonomous regions and 4 municipalities participated in the surveys. The survey tools were a series of self-designed questionnaires with high inheritance and consistency designed and implemented by the NHFPC. The questionnaires mainly contain basic information of the respondents and their family members, migration status, healthcare or health behaviors, public health service utilization, social insurance, social integration, and family planning. The dataset is currently the most widely used survey data on China’s internal migrants, offering information on migration patterns, healthcare and health behaviors, use of public health services, access to social security, social integration, and family planning, which are valuable for health planning, health decision-making, and health equity research.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 3","pages":"Pages 235-241"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10167622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert Consensus on Acute Respiratory Failure in Critically III Cancer Patients (2023) 危重III级癌症患者急性呼吸衰竭专家共识(2023)
Q2 Medicine Pub Date : 2023-09-01 DOI: 10.24920/004203
Hai-Jun Wang , Wei Chen , Hong-Zhi Wang , He-Ling Zhao , Dong-Hao Wang , Yun Long , Xue-Zhong Xing , on behalf of the Critical Care Medicine Committee of Beijing Association of Oncology (CCMBAO)

Objective

This consensus aims to provide evidence-based recommendations on common questions in the diagnosis and treatment of acute respiratory failure (ARF) for critically ill cancer patients.

Methods

We developed six clinical questions using the PICO (Population, Intervention, Comparison, and Outcome) principle in diagnosis and treatment for critical ill cancer patients with ARF. Based on literature searching and meta-analyses, recommendations were devised. The GRADE (Grading of Recommendation Assessment, Development and Evaluation) method was applied to each question to reach consensus in the expert panel.

Results

The panel makes strong recommendations in favor of (1) metagenomic next-generation sequencing (mNGS) tests may aid clinicians in rapid diagnosis in critically ill cancer patients suspected of pulmonary infections; (2) extracorporeal membrane oxygenation (ECMO) therapy should not be used as a routine rescue therapy for acute respiratory distress syndrome in critically ill cancer patients but may benefit highly selected patients after multi-disciplinary consultations; (3) cancer patients who have received immune checkpoint inhibitor therapy have an increased incidence of pneumonitis compared with standard chemotherapy; (4) critically ill cancer patients who are on invasive mechanical ventilation and estimated to be extubated after 14 days may benefit from early tracheotomy; and (5) high-flow nasal oxygen and noninvasive ventilation therapy can be used as a first-line oxygen strategy for critically ill cancer patients with ARFs. A weak recommendation is: (6) for critically ill cancer patients with ARF caused by tumor compression, urgent chemotherapy may be considered as a rescue therapy only in patients determined to be potentially sensitive to the anticancer therapy after multidisciplinary consultations.

Conclusions

The recommendations based on the available evidence can guide diagnosis and treatment in critically ill cancer patients with acute respiratory failure and improve outcomes.

目的本共识旨在为危重癌症患者急性呼吸衰竭(ARF)的诊断和治疗中的常见问题提供循证建议。方法应用PICO(群体、干预、比较和结果)原则对危重癌症ARF患者进行诊断和治疗,提出6个临床问题。在文献检索和荟萃分析的基础上,提出了建议。将GRADE(推荐评估、发展和评估分级)方法应用于每个问题,以在专家小组中达成共识。结果该小组强烈建议:(1)宏基因组下一代测序(mNGS)测试可能有助于临床医生对怀疑肺部感染的危重癌症患者进行快速诊断;(2) 体外膜肺氧合(ECMO)治疗不应作为危重癌症患者急性呼吸窘迫综合征的常规抢救治疗,但可在多学科会诊后使高度选择的患者受益;(3) 与标准化疗相比,接受免疫检查点抑制剂治疗的癌症患者肺炎发病率增加;(4) 正在接受有创机械通气并估计14天后拔管的癌症危重患者可能受益于早期气管切开术;(5)高流量鼻氧和无创通气治疗可作为危重癌症ARF患者的一线氧气策略。一个较弱的建议是:(6)对于因肿瘤压迫引起的危重癌症ARF患者,只有在多学科咨询后确定对抗癌治疗潜在敏感的患者,才可以考虑将紧急化疗作为抢救性治疗。结论根据现有证据提出的建议可指导危重癌症急性呼吸衰竭患者的诊断和治疗,改善预后。
{"title":"Expert Consensus on Acute Respiratory Failure in Critically III Cancer Patients (2023)","authors":"Hai-Jun Wang ,&nbsp;Wei Chen ,&nbsp;Hong-Zhi Wang ,&nbsp;He-Ling Zhao ,&nbsp;Dong-Hao Wang ,&nbsp;Yun Long ,&nbsp;Xue-Zhong Xing ,&nbsp;on behalf of the Critical Care Medicine Committee of Beijing Association of Oncology (CCMBAO)","doi":"10.24920/004203","DOIUrl":"https://doi.org/10.24920/004203","url":null,"abstract":"<div><h3>Objective</h3><p>This consensus aims to provide evidence-based recommendations on common questions in the diagnosis and treatment of acute respiratory failure (ARF) for critically ill cancer patients.</p></div><div><h3>Methods</h3><p>We developed six clinical questions using the PICO (Population, Intervention, Comparison, and Outcome) principle in diagnosis and treatment for critical ill cancer patients with ARF. Based on literature searching and meta-analyses, recommendations were devised. The GRADE (Grading of Recommendation Assessment, Development and Evaluation) method was applied to each question to reach consensus in the expert panel.</p></div><div><h3>Results</h3><p>The panel makes strong recommendations in favor of (1) metagenomic next-generation sequencing (mNGS) tests may aid clinicians in rapid diagnosis in critically ill cancer patients suspected of pulmonary infections; (2) extracorporeal membrane oxygenation (ECMO) therapy should not be used as a routine rescue therapy for acute respiratory distress syndrome in critically ill cancer patients but may benefit highly selected patients after multi-disciplinary consultations; (3) cancer patients who have received immune checkpoint inhibitor therapy have an increased incidence of pneumonitis compared with standard chemotherapy; (4) critically ill cancer patients who are on invasive mechanical ventilation and estimated to be extubated after 14 days may benefit from early tracheotomy; and (5) high-flow nasal oxygen and noninvasive ventilation therapy can be used as a first-line oxygen strategy for critically ill cancer patients with ARFs. A weak recommendation is: (6) for critically ill cancer patients with ARF caused by tumor compression, urgent chemotherapy may be considered as a rescue therapy only in patients determined to be potentially sensitive to the anticancer therapy after multidisciplinary consultations.</p></div><div><h3>Conclusions</h3><p>The recommendations based on the available evidence can guide diagnosis and treatment in critically ill cancer patients with acute respiratory failure and improve outcomes.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 3","pages":"Pages 163-177"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67739985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Medication Rules of Traditional Chinese Medicine for Malaria Treatment Based on Data Mining 【基于数据挖掘的中医药治疗疟疾用药规律分析】。
Q2 Medicine Pub Date : 2023-09-01 DOI: 10.24920/004214
Wen-Long Guo , Hui-Juan Jiang , Yan-Rong Li , Jin-Long Yang

Objective

To analyze the medication rules of traditional Chinese medicine (TCM) for malaria treatment.

Methods

Statistical analysis was conducted on the basic attributes of TCM drugs with regard to property, therapeutic methods, flavor, and meridian tropism. A complex network of TCM drug associations was constructed. Cluster analysis was applied to obtain the core drugs for malaria treatment. The Apriori algorithm was applied to analyze the association rules of these core drugs.

Results

A total of 3S7 herbs were used 3,194 times in 461 prescriptions for malaria treatment. Radix Glycyrrhizae (

), Rhizoma Pinelliae (
), Radix Bupleuri (
), and Radix Dichroae (
) were the frequently used herbs through supplementing, exterior-releasing, heat-clearing, qi-rectifying, and damp-resolving therapeutic methods. Such herbs had warm, natural, and cold herbal properties; pungent, bitter, and sweet flavors; and spleen, lung, and stomach meridian tropisms. Cluster analysis showed 61 core drugs, including Radix Glycyrrhizae, Rhizoma Pinelliae, Radix Bupleuri, and Radix Scutellariae (
). Apriori association rule analysis yielded 12 binomial rules (herb pairs) and 6 trinomial rules (herb combinations). Radix Bupleuri plus Radix Scutellariae was the core herbal pair for treating malaria. This pair could be combined with Rhizoma Atractylodis Macrocephalae (
) for treating warm or cold malaria, combined with Pericarpium Citri Reticulatae (
) or Radix Dichroae (
) for treating miasmic malaria, or combined with turtle shells (
) for treating malaria with splenomegaly.

Conclusions

TCM can be used to classify and treat malaria in accordance with the different stages of development. As the core herbal pair, Radix Bupleuri and Radix Scutellariae can be combined with other drugs to treat malaria with different syndrome types.

目的分析中医药治疗疟疾的用药规律。方法对中药的性质、治疗方法、味性、归经性等基本属性进行统计分析。构建了一个复杂的中医药协会网络。应用聚类分析获得了治疗疟疾的核心药物。应用Apriori算法对这些核心药物的关联规则进行了分析。结果在461个疟疾治疗处方中,共使用357种中草药3194次。甘草()、山茶()、柴胡()、二胡()是常用的补、表、清热、正气、解湿的中草药。这些草药具有温暖、天然和寒冷的草药特性;辛、苦、甜的味道;以及脾、肺和胃经的斜视。聚类分析显示了61种核心药物,包括甘草、黄连、柴胡和黄芩()。Apriori关联规则分析得到12个二项式规则(草本配对)和6个三项规则(草本组合)。柴胡加黄芩是治疗疟疾的核心药对。本品可与白术()联用治疗温性或寒性疟疾,与陈皮()或地黄()联用药治疗疟疾,或与甲壳类动物()联合用药治疗疟疾伴脾肿大。结论中医药可根据疟疾的不同发展阶段对其进行分类和治疗。柴胡和黄芩作为核心药对,可与其他药物联合治疗不同证型的疟疾。
{"title":"Analysis of Medication Rules of Traditional Chinese Medicine for Malaria Treatment Based on Data Mining","authors":"Wen-Long Guo ,&nbsp;Hui-Juan Jiang ,&nbsp;Yan-Rong Li ,&nbsp;Jin-Long Yang","doi":"10.24920/004214","DOIUrl":"10.24920/004214","url":null,"abstract":"<div><h3>Objective</h3><p>To analyze the medication rules of traditional Chinese medicine (TCM) for malaria treatment.</p></div><div><h3>Methods</h3><p>Statistical analysis was conducted on the basic attributes of TCM drugs with regard to property, therapeutic methods, flavor, and meridian tropism. A complex network of TCM drug associations was constructed. Cluster analysis was applied to obtain the core drugs for malaria treatment. The Apriori algorithm was applied to analyze the association rules of these core drugs.</p></div><div><h3>Results</h3><p>A total of 3S7 herbs were used 3,194 times in 461 prescriptions for malaria treatment. <em>Radix Glycyrrhizae</em> (<figure><img></figure>), <em>Rhizoma Pinelliae</em> (<figure><img></figure>), <em>Radix Bupleuri</em> (<figure><img></figure>), and <em>Radix Dichroae</em> (<figure><img></figure>) were the frequently used herbs through supplementing, exterior-releasing, heat-clearing, qi-rectifying, and damp-resolving therapeutic methods. Such herbs had warm, natural, and cold herbal properties; pungent, bitter, and sweet flavors; and spleen, lung, and stomach meridian tropisms. Cluster analysis showed 61 core drugs, including <em>Radix Glycyrrhizae, Rhizoma Pinelliae, Radix Bupleuri,</em> and <em>Radix Scutellariae</em> (<figure><img></figure>). Apriori association rule analysis yielded 12 binomial rules (herb pairs) and 6 trinomial rules (herb combinations). <em>Radix Bupleuri</em> plus <em>Radix Scutellariae</em> was the core herbal pair for treating malaria. This pair could be combined with <em>Rhizoma Atractylodis Macrocephalae</em> (<figure><img></figure>) for treating warm or cold malaria, combined with <em>Pericarpium Citri Reticulatae</em> (<figure><img></figure>) or <em>Radix Dichroae</em> (<figure><img></figure>) for treating miasmic malaria, or combined with turtle shells (<figure><img></figure>) for treating malaria with splenomegaly.</p></div><div><h3>Conclusions</h3><p>TCM can be used to classify and treat malaria in accordance with the different stages of development. As the core herbal pair, <em>Radix Bupleuri</em> and <em>Radix Scutellariae</em> can be combined with other drugs to treat malaria with different syndrome types.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 3","pages":"Pages 218-227"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9690740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening the Disciplinary Construction of History of Medicine: A Call for Action by Chinese Academy of Medical Sciences & Peking Union Medical College 加强医学史学科建设——中国医学科学院和北京协和医学院的行动呼吁
Q2 Medicine Pub Date : 2023-06-01 DOI: 10.24920/004270
Jian-Hong Yao , Da-Qing Zhang , Xin-Zhong Yu , Shu-Jian Zhang , Yong-An Zhang , Xiang-Yin Yang , Zhong He , Huan Liu , Yong Wang , Yue-Ying Jin
{"title":"Strengthening the Disciplinary Construction of History of Medicine: A Call for Action by Chinese Academy of Medical Sciences & Peking Union Medical College","authors":"Jian-Hong Yao ,&nbsp;Da-Qing Zhang ,&nbsp;Xin-Zhong Yu ,&nbsp;Shu-Jian Zhang ,&nbsp;Yong-An Zhang ,&nbsp;Xiang-Yin Yang ,&nbsp;Zhong He ,&nbsp;Huan Liu ,&nbsp;Yong Wang ,&nbsp;Yue-Ying Jin","doi":"10.24920/004270","DOIUrl":"10.24920/004270","url":null,"abstract":"","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 2","pages":"Pages 94-96"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9917830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chinese Guideline on the Management of Polypoidal Choroidal Vasculopathy (2022) 中国息肉状脉络膜血管病治疗指南(2022)。
Q2 Medicine Pub Date : 2023-06-01 DOI: 10.24920/004213
You-Xin Cher , Yu-Qing Zhang , Chang-Zheng Chen , Hong Dai , Su-Yan Li , Xiang Ma , Xiao-Dong Sun , Shi-Bo Tang , Yu-Sheng Wang , Wen-Bin Wei , Feng Wen , Ge-Zhi Xu , Wei-Hong Yu , Mei-Xia Zhang , Ming-Wei Zhao , Yang Zhang , Fang Qi , Xun Xu , Xiao-Xin Li

Background

In mainland China, patients with neovascular age-related macular degeneration (nAMD) have approximately an 40% prevalence of polypoidal choroidal vasculopathy (PCV). This disease leads to recurrent retinal pigment epithelium detachment (PED), extensive subretinal or vitreous hemorrhages, and severe vision loss. China has introduced various treatment modalities in the past years and gained comprehensive experience in treating PCV.

Methods

A total of 14 retinal specialists nationwide with expertise in PCV were empaneled to prioritize six questions and address their corresponding outcomes, regarding opinions on inactive PCV, choices of anti-vascular endothelial growth factor (anti-VEGF) monotherapy, photodynamic therapy (PDT) monotherapy or combined therapy, patients with persistent subretinal fluid (SRF) or intraretinal fluid (IRF) after loading dose anti-VEGF, and patients with massive subretinal hemorrhage. An evidence synthesis team conducted systematic reviews, which informed the recommendations that address these questions. This guideline used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach to assess the certainty of evidence and grade the strengths of recommendations.

Results

The panel proposed the following six conditional recommendations regarding treatment choices. (1) For patients with inactive PCV, we suggest observation over treatment. (2) For treatment-naive PCV patients, we suggest either anti-VEGF monotherapy or combined anti-VEGF and PDT rather than PDT monotherapy. (3) For patients with PCV who plan to initiate combined anti-VEGF and PDT treatment, we suggest later/rescue PDT over initiate PDT. (4) For PCV patients who plan to initiate anti-VEGF monotherapy, we suggest the treat and extend (T&E) regimen rather than the pro re nata (PRN) regimen following three monthly loading doses. (5) For patients with persistent SRF or IRF on optical coherence tomography (OCT) after three monthly anti-VEGF treatments, we suggest proceeding with anti-VEGF treatment rather than observation. (6) For PCV patients with massive subretinal hemorrhage (equal to or more than four optic disc areas) involving the central macula, we suggest surgery (vitrectomy in combination with tissue-plasminogen activator (tPA) intraocular injection and gas tamponade) rather than anti-VEGF monotherapy.

Conclusions

Six evidence-based recommendations support optimal care for PCV patients’ management.

背景在中国大陆,新生血管性年龄相关性黄斑变性(nAMD)患者的息肉状脉络膜血管病(PCV)患病率约为40%。这种疾病会导致复发性视网膜色素上皮脱离(PED)、广泛的视网膜下或玻璃体出血和严重的视力丧失。在过去的几年里,中国引入了各种治疗方式,并在治疗PCV方面获得了全面的经验,光动力疗法(PDT)单药治疗或联合治疗,负载剂量抗VEGF后出现持续性视网膜下液(SRF)或视网膜内液(IRF)的患者,以及大量视网膜下出血的患者。一个证据综合小组进行了系统审查,为解决这些问题的建议提供了信息。本指南使用GRADE(建议、评估、发展和评估的分级)方法来评估证据的确定性,并对建议的强度进行分级。结果专家组就治疗选择提出了以下六项有条件的建议。(1) 对于无活动性PCV的患者,我们建议观察多于治疗。(2) 治疗na?对于PCV患者,我们建议抗VEGF单药治疗或抗VEGF和PDT联合治疗,而不是PDT单药治疗。(3) 对于计划开始联合抗VEGF和PDT治疗的PCV患者,我们建议后期/挽救PDT而不是开始PDT。(4) 对于计划开始抗VEGF单药治疗的PCV患者,我们建议在三个月的负荷剂量后采用治疗和延长(T&E)方案,而不是出生前(PRN)方案。(5) 对于在光学相干断层扫描(OCT)上进行为期三个月的抗VEGF治疗后出现持续性SRF或IRF的患者,我们建议继续进行抗VEGF治疗,而不是观察。(6) 对于涉及中央黄斑的大量视网膜下出血(等于或超过四个视盘区域)的PCV患者,我们建议手术(玻璃体切除联合组织纤溶酶原激活剂(tPA)眼内注射和气体填塞),而不是抗VEGF单药治疗。结论六项循证建议支持PCV患者的最佳护理管理。
{"title":"Chinese Guideline on the Management of Polypoidal Choroidal Vasculopathy (2022)","authors":"You-Xin Cher ,&nbsp;Yu-Qing Zhang ,&nbsp;Chang-Zheng Chen ,&nbsp;Hong Dai ,&nbsp;Su-Yan Li ,&nbsp;Xiang Ma ,&nbsp;Xiao-Dong Sun ,&nbsp;Shi-Bo Tang ,&nbsp;Yu-Sheng Wang ,&nbsp;Wen-Bin Wei ,&nbsp;Feng Wen ,&nbsp;Ge-Zhi Xu ,&nbsp;Wei-Hong Yu ,&nbsp;Mei-Xia Zhang ,&nbsp;Ming-Wei Zhao ,&nbsp;Yang Zhang ,&nbsp;Fang Qi ,&nbsp;Xun Xu ,&nbsp;Xiao-Xin Li","doi":"10.24920/004213","DOIUrl":"10.24920/004213","url":null,"abstract":"<div><h3>Background</h3><p>In mainland China, patients with neovascular age-related macular degeneration (nAMD) have approximately an 40% prevalence of polypoidal choroidal vasculopathy (PCV). This disease leads to recurrent retinal pigment epithelium detachment (PED), extensive subretinal or vitreous hemorrhages, and severe vision loss. China has introduced various treatment modalities in the past years and gained comprehensive experience in treating PCV.</p></div><div><h3>Methods</h3><p>A total of 14 retinal specialists nationwide with expertise in PCV were empaneled to prioritize six questions and address their corresponding outcomes, regarding opinions on inactive PCV, choices of anti-vascular endothelial growth factor (anti-VEGF) monotherapy, photodynamic therapy (PDT) monotherapy or combined therapy, patients with persistent subretinal fluid (SRF) or intraretinal fluid (IRF) after loading dose anti-VEGF, and patients with massive subretinal hemorrhage. An evidence synthesis team conducted systematic reviews, which informed the recommendations that address these questions. This guideline used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach to assess the certainty of evidence and grade the strengths of recommendations.</p></div><div><h3>Results</h3><p>The panel proposed the following six conditional recommendations regarding treatment choices. (1) For patients with inactive PCV, we suggest observation over treatment. (2) For treatment-naive PCV patients, we suggest either anti-VEGF monotherapy or combined anti-VEGF and PDT rather than PDT monotherapy. (3) For patients with PCV who plan to initiate combined anti-VEGF and PDT treatment, we suggest later/rescue PDT over initiate PDT. (4) For PCV patients who plan to initiate anti-VEGF monotherapy, we suggest the treat and extend (T&amp;E) regimen rather than the <em>pro re nata</em> (PRN) regimen following three monthly loading doses. (5) For patients with persistent SRF or IRF on optical coherence tomography (OCT) after three monthly anti-VEGF treatments, we suggest proceeding with anti-VEGF treatment rather than observation. (6) For PCV patients with massive subretinal hemorrhage (equal to or more than four optic disc areas) involving the central macula, we suggest surgery (vitrectomy in combination with tissue-plasminogen activator (tPA) intraocular injection and gas tamponade) rather than anti-VEGF monotherapy.</p></div><div><h3>Conclusions</h3><p>Six evidence-based recommendations support optimal care for PCV patients’ management.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 2","pages":"Pages 77-93"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9845803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterogeneity of Outcomes Reporting in Trials Evaluating Traditional Chinese Medicine Breast Massage for Stasis Acute Mastitis: A Methodological Review 中医乳腺按摩治疗瘀阻性急性乳房炎试验结果报告的异质性:方法学综述
Q2 Medicine Pub Date : 2023-06-01 DOI: 10.24920/004164
Yun-Peng Lv , Ting Yuan , Xiao-Ying Mu , Ying-Yi Fan , Ming-Yang An , Fen Zhou

Objective

To systematically analyze the current status of outcomes reporting in clinical trials on treating stasis acute mastitis with Traditional Chinese Medicine breast massage.

Methods

We searched CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, Embase, Cochrane library, JBI, CINAHL, PsycINFO, Clinical Trials Registry Platform portal, Clinical Trials Registry, Australian New Zealand Clinical Trials Registry, Center Watch Registry from inception to May IS, 2022 to find randomized controlled trials, non-randomized controlled trials, case series and cohort studies which reported the outcomes of stasis acute mastitis managed with Traditional Chinese Medicine breast massage, with search terms of mastitis, acute mastitis, lactation mastitis, puerperal mastitis, breast problem, breast engorgement, milk stasis, blocked ducked, breast pain, breast massage, and acupoint massage. Outcomes and the measurement schemes (measurement methods, timing of assessing outcome, frequency of assessing outcome, measurers) were extracted from the included studies. We used the Management of Otitis Media with Effusion in Children with Cleft Palate (MOMENT) to assess the quality of each study, then categorized outcomes derived from the included studies into different domains according to the Outcome Measures in Rheumatology Arthritis Clinic Trials (OMERACT) Filter 2.1 framework.

Results

We identified 85 clinical trials, in which 54 different outcomes were reported. A total of 81.2% (69/85) of studies were assessed as medium quality with a mean score of 2.6, and 18.8% (16/85) as low quality with a mean score of 0.9. These outcomes were organized in three core areas. Lump size (89.4%, 76/85) was the most frequently reported outcome, followed by breast pain (69.4%, 59/85) and milk excretion (68.2%, 58/85). Five methods were used to assess lump size and four methods to assess breast pain.

Conclusions

The outcomes reported in clinical trials regarding stasis acute mastitis treated by Traditional Chinese Medicine breast massage are heterogeneous. Developing a core outcome set to achieve consistent standards for reporting outcomes and modalities for validation of the outcomes is clearly warranted.

目的系统分析中医推拿治疗瘀阻型急性乳腺炎的临床疗效报告现状。方法检索CNKI、万方、VIP、SinoMed、PubMed、Web of Science、Embase、Cochrane library、JBI、CINAHL、PsycINFO、临床试验注册平台门户网站、临床试验注册表、澳大利亚-新西兰临床试验注册中心、中心观察注册中心,从成立到2022年5月,病例系列和队列研究报告了用中医乳房按摩治疗淤滞性急性乳腺炎的结果,检索词为乳腺炎、急性乳腺病、哺乳期乳房炎、产褥期乳腺炎,乳房问题、乳房充血、乳汁淤滞、阻乳、乳房疼痛、乳房按摩和穴位按摩。从纳入的研究中提取结果和测量方案(测量方法、评估结果的时间、评估结果频率、测量者)。我们使用腭裂儿童渗出性中耳炎的管理(MOMENT)来评估每项研究的质量,然后根据风湿病关节炎临床试验的结果测量(OMERACT)过滤器2.1框架将纳入研究的结果分为不同的领域。结果我们确定了85项临床试验,其中报告了54种不同的结果。共有81.2%(69/85)的研究被评估为中等质量,平均得分为2.6,18.8%(16/85)被评估为低质量,平均分数为0.9。这些成果分为三个核心领域。肿块大小(89.4%,76/85)是最常见的报告结果,其次是乳房疼痛(69.4%,59/85)和乳汁排泄(68.2%,58/85)。采用五种方法评估肿块大小,四种方法评估乳房疼痛。结论中医推拿治疗瘀阻型急性乳腺炎的临床疗效参差不齐。显然有必要制定一套核心成果集,以实现一致的成果报告标准和成果验证模式。
{"title":"Heterogeneity of Outcomes Reporting in Trials Evaluating Traditional Chinese Medicine Breast Massage for Stasis Acute Mastitis: A Methodological Review","authors":"Yun-Peng Lv ,&nbsp;Ting Yuan ,&nbsp;Xiao-Ying Mu ,&nbsp;Ying-Yi Fan ,&nbsp;Ming-Yang An ,&nbsp;Fen Zhou","doi":"10.24920/004164","DOIUrl":"10.24920/004164","url":null,"abstract":"<div><h3>Objective</h3><p>To systematically analyze the current status of outcomes reporting in clinical trials on treating stasis acute mastitis with Traditional Chinese Medicine breast massage.</p></div><div><h3>Methods</h3><p>We searched CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, Embase, Cochrane library, JBI, CINAHL, PsycINFO, Clinical Trials Registry Platform portal, Clinical Trials Registry, Australian New Zealand Clinical Trials Registry, Center Watch Registry from inception to May IS, 2022 to find randomized controlled trials, non-randomized controlled trials, case series and cohort studies which reported the outcomes of stasis acute mastitis managed with Traditional Chinese Medicine breast massage, with search terms of mastitis, acute mastitis, lactation mastitis, puerperal mastitis, breast problem, breast engorgement, milk stasis, blocked ducked, breast pain, breast massage, and acupoint massage. Outcomes and the measurement schemes (measurement methods, timing of assessing outcome, frequency of assessing outcome, measurers) were extracted from the included studies. We used the Management of Otitis Media with Effusion in Children with Cleft Palate (MOMENT) to assess the quality of each study, then categorized outcomes derived from the included studies into different domains according to the Outcome Measures in Rheumatology Arthritis Clinic Trials (OMERACT) Filter 2.1 framework.</p></div><div><h3>Results</h3><p>We identified 85 clinical trials, in which 54 different outcomes were reported. A total of 81.2% (69/85) of studies were assessed as medium quality with a mean score of 2.6, and 18.8% (16/85) as low quality with a mean score of 0.9. These outcomes were organized in three core areas. Lump size (89.4%, 76/85) was the most frequently reported outcome, followed by breast pain (69.4%, 59/85) and milk excretion (68.2%, 58/85). Five methods were used to assess lump size and four methods to assess breast pain.</p></div><div><h3>Conclusions</h3><p>The outcomes reported in clinical trials regarding stasis acute mastitis treated by Traditional Chinese Medicine breast massage are heterogeneous. Developing a core outcome set to achieve consistent standards for reporting outcomes and modalities for validation of the outcomes is clearly warranted.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 2","pages":"Pages 147-158"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9873398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-Appraisal of Clinical Competence in Echocardiography of Chinese Intensivists Post Basic Echocardiography Training 基础超声心动图训练后我国高师超声心动图临床能力的自我评价
Q2 Medicine Pub Date : 2023-06-01 DOI: 10.24920/004174
Wei He , Xue-Ying Zeng , Hong-Min Zhang , Xiao-Ting Wang , Yan-Gong Chao , Critical Care Ultrasound Study Group

Objectives

To learn the echocardiography skills of intensivists after receiving a basic critical care echocardiography training course, and investigate factors that may influence their performance.

Methods

We completed a web-based questionnaire that assessed the skills in ultrasound scanning techniques of intensivists who took a training course on basic critical care echocardiography held in 2019 and 2020. Mann-Whitney test was used to analyze the factors which might affect their performance on image acquisition, recognizing clinical syndrome, and measuring the diameter of inferior vena cava, left ventricular ejection fraction and left ventricular outflow tract velocity-time integral.

Results

We enrolled 554 physicians from 412 intensive care units across China. Among them, 185 (33.4%) reported that they had 10%–30% chance of being misled by critical care echocardiography when making therapeutic decision, and 34 (6.1%) reported that the chance was greater than 30%. Intensivists who performed echocardiography under the guidance of a mentor and finished ultrasound scanning more than 10 times per week reported significant higher scores in image acquisition, clinical syndrome recognition, and quantitative measurement of inferior vena cava diameter, left ventricular ejection fraction and left ventricular outflow tract velocity-time integral than those without mentor and performing echocardiography 10 times or less per week respectively (all p < 0.05).

Conclusion

The skills in diagnostic medical echocardiography of Chinese intensivists after a basic echocardiographic training course remain low, and further quality assurance training program is clearly warranted.

目的了解重症监护医师在接受基础重症监护超声心动图培训后的超声心动图技能,并探讨可能影响其表现的因素。方法我们完成了一份基于网络的问卷,评估了参加2019年和2020年举办的基础重症监护超声心动图培训课程的重症监护医生的超声扫描技术技能。Mann-Whitney检验用于分析可能影响他们在图像采集、识别临床综合征、测量下腔静脉直径、左心室射血分数和左心室流出道速度-时间积分方面表现的因素。结果我们招募了来自中国412个重症监护室的554名医生。其中,185人(33.4%)报告称,他们在做出治疗决定时被重症监护超声心动图误导的几率为10%-30%,34人(6.1%)报告称这种几率大于30%。在导师的指导下进行超声心动图检查并每周完成10次以上超声扫描的强化医生报告称,他们在图像采集、临床综合征识别和下腔静脉直径定量测量方面的得分显著较高,左心室射血分数和左心室流出道速度时间积分分别低于无导师和每周超声心动图检查10次或更少的患者(均p<0.05),进一步的质量保证培训计划显然是有必要的。
{"title":"Self-Appraisal of Clinical Competence in Echocardiography of Chinese Intensivists Post Basic Echocardiography Training","authors":"Wei He ,&nbsp;Xue-Ying Zeng ,&nbsp;Hong-Min Zhang ,&nbsp;Xiao-Ting Wang ,&nbsp;Yan-Gong Chao ,&nbsp;Critical Care Ultrasound Study Group","doi":"10.24920/004174","DOIUrl":"10.24920/004174","url":null,"abstract":"<div><h3>Objectives</h3><p>To learn the echocardiography skills of intensivists after receiving a basic critical care echocardiography training course, and investigate factors that may influence their performance.</p></div><div><h3>Methods</h3><p>We completed a web-based questionnaire that assessed the skills in ultrasound scanning techniques of intensivists who took a training course on basic critical care echocardiography held in 2019 and 2020. Mann-Whitney test was used to analyze the factors which might affect their performance on image acquisition, recognizing clinical syndrome, and measuring the diameter of inferior vena cava, left ventricular ejection fraction and left ventricular outflow tract velocity-time integral.</p></div><div><h3>Results</h3><p>We enrolled 554 physicians from 412 intensive care units across China. Among them, 185 (33.4%) reported that they had 10%–30% chance of being misled by critical care echocardiography when making therapeutic decision, and 34 (6.1%) reported that the chance was greater than 30%. Intensivists who performed echocardiography under the guidance of a mentor and finished ultrasound scanning more than 10 times per week reported significant higher scores in image acquisition, clinical syndrome recognition, and quantitative measurement of inferior vena cava diameter, left ventricular ejection fraction and left ventricular outflow tract velocity-time integral than those without mentor and performing echocardiography 10 times or less per week respectively (all <em>p &lt;</em> 0.05).</p></div><div><h3>Conclusion</h3><p>The skills in diagnostic medical echocardiography of Chinese intensivists after a basic echocardiographic training course remain low, and further quality assurance training program is clearly warranted.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 2","pages":"Pages 125-129"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9916247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of Mean Value of Central Venous Pressure from Monitor Digital Display: Influence of Amplitude of Central Venous Pressure during Respiration 监护仪数字显示中心静脉压力平均值的准确性:呼吸时中心静脉压力振幅的影响
Q2 Medicine Pub Date : 2023-06-01 DOI: 10.24920/004158
Meng-Ru Xu , Wang-Lin Liu , Huai-Wu He , Xiao-Li Lai , Mei-Ling Zhao , Da-Wei Liu , Yun Long

Background

A simple measurement of central venous pressure (CVP)-mean by the digital monitor display has become increasingly popular. However, the agreement between CVP-mean and CVP-end (a standard method of CVP measurement by analyzing the waveform at end-expiration) is not well determined. This study was designed to identify the relationship between CVP-mean and CVP-end in critically ill patients and to introduce a new parameter of CVP amplitude (ΔCVP= CVPmax – CVPmin) during the respiratory period to identify the agreement/disagreement between CVP-mean and CVP-end.

Methods

In total, 291 patients were included in the study. CVP-mean and CVP-end were obtained simultaneously from each patient. CVP measurement difference (| CVP-mean – CVP-end |) was defined as the difference between CVP-mean and CVP-end. The ΔCVP was calculated as the difference between the peak (CVPmax) and the nadir value (CVPmin) during the respiratory cycle, which was automatically recorded on the monitor screen. Subjects with | CVP-mean – CVP-end | ≥ 2 mmHg were divided into the inconsistent group, while subjects with | CVP-mean – CVP-end | < 2 mmHg were divided into the consistent group.

Results

ΔCVP was significantly higher in the inconsistent group [7.17(2.77) vs.5.24(2.18), p<0.001] than that in the consistent group. There was a significantly positive relationship between ΔCVP and | CVP-mean – CVP-end | (r=0.283, p <0.0001). Bland-Altman plot showed the bias was -0.61 mmHg with a wide 95% limit of agreement (–3.34, 2.10) of CVP-end and CVP-mean. The area under the receiver operating characteristic curves (AUC) of ΔCVP for predicting | CVP-mean – CVP-end | ≥ 2 mmHg was 0.709. With a high diagnostic specificity, using ΔCVP<3 to detect | CVP-mean – CVP-end | lower than 2mmHg (consistent measurement) resulted in a sensitivity of 22.37% and a specificity of 93.06%. Using ΔCVP>8 to detect | CVP-mean – CVP-end | >8 mmHg (inconsistent measurement) resulted in a sensitivity of 31.94% and a specificity of 91.32%.

Conclusions

Conclusions CVP-end and CVP-mean have statistical discrepancies in specific clinical scenarios. ΔCVP during the respiratory period is related to the variation of the two CVP methods. A high ΔCVP indicates a poor agreement between these two methods, whereas a low ΔCVP indicates a good agreement between these two methods.

背景利用数字显示器对中心静脉压(CVP)进行简单的测量越来越受欢迎。然而,CVP平均值和CVP结束值(通过分析结束时的波形来测量CVP的标准方法)之间的一致性并没有很好地确定。本研究旨在确定危重患者CVP平均值和CVP终点之间的关系,并引入呼吸期CVP振幅的新参数(ΔCVP=CVPmax–CVPmin),以确定CVP平均数和CVP末端之间的一致性/不一致性。方法共有291名患者纳入本研究。同时获得每位患者的CVP平均值和CVP终点。CVP测量差异(|CVP均值–CVP终点|)定义为CVP均值和CVP终点之间的差异。ΔCVP计算为呼吸周期中峰值(CVPmax)和最低点(CVPmin)之间的差值,并自动记录在监视器屏幕上。将|CVP均值-CVP终点|≥2 mmHg的受试者分为不一致组,而|CVP平均值-CVP末端|<;2mmHg分为一致组。结果不一致组的ΔCVP显著高于一致组[7.17(2.77)vs.5.24(2.18),p<;0.001]。ΔCVP与|CVP平均值–CVP终点之间存在显著的正相关关系(r=0.283,p<;0.0001)。Bland-Altman图显示偏差为-0.61 mmHg,CVP终点与CVP均值的一致性范围为95%(–3.34,2.10)。预测|CVP平均值–CVP终点|≥2 mmHg的ΔCVP受试者工作特征曲线下面积(AUC)为0.709。ΔCVP<;3检测|CVP平均值–CVP终点|低于2mmHg(一致测量)的灵敏度为22.37%,特异性为93.06%;8检测|CVP平均值–CVP结束|>;8mmHg(测量不一致)的敏感性为31.94%,特异性为91.32%。结论CVP终点和CVP平均值在特定临床情况下存在统计学差异。ΔCVP与两种CVP方法的变化有关。ΔCVP高表示这两种方法之间的一致性较差,而ΔCVP低表示这两个方法之间的良好一致性。
{"title":"Accuracy of Mean Value of Central Venous Pressure from Monitor Digital Display: Influence of Amplitude of Central Venous Pressure during Respiration","authors":"Meng-Ru Xu ,&nbsp;Wang-Lin Liu ,&nbsp;Huai-Wu He ,&nbsp;Xiao-Li Lai ,&nbsp;Mei-Ling Zhao ,&nbsp;Da-Wei Liu ,&nbsp;Yun Long","doi":"10.24920/004158","DOIUrl":"10.24920/004158","url":null,"abstract":"<div><h3>Background</h3><p>A simple measurement of central venous pressure (CVP)-mean by the digital monitor display has become increasingly popular. However, the agreement between CVP-mean and CVP-end (a standard method of CVP measurement by analyzing the waveform at end-expiration) is not well determined. This study was designed to identify the relationship between CVP-mean and CVP-end in critically ill patients and to introduce a new parameter of CVP amplitude (ΔCVP= CVPmax – CVPmin) during the respiratory period to identify the agreement/disagreement between CVP-mean and CVP-end.</p></div><div><h3>Methods</h3><p>In total, 291 patients were included in the study. CVP-mean and CVP-end were obtained simultaneously from each patient. CVP measurement difference (| CVP-mean – CVP-end |) was defined as the difference between CVP-mean and CVP-end. The ΔCVP was calculated as the difference between the peak (CVPmax) and the nadir value (CVPmin) during the respiratory cycle, which was automatically recorded on the monitor screen. Subjects with | CVP-mean – CVP-end | ≥ 2 mmHg were divided into the inconsistent group, while subjects with | CVP-mean – CVP-end | &lt; 2 mmHg were divided into the consistent group.</p></div><div><h3>Results</h3><p>ΔCVP was significantly higher in the inconsistent group [7.17(2.77) <em>vs</em>.5.24(2.18), <em>p</em>&lt;0.001] than that in the consistent group. There was a significantly positive relationship between ΔCVP and | CVP-mean – CVP-end | (<em>r</em>=0.283, <em>p</em> &lt;0.0001). Bland-Altman plot showed the bias was -0.61 mmHg with a wide 95% limit of agreement (–3.34, 2.10) of CVP-end and CVP-mean. The area under the receiver operating characteristic curves (AUC) of ΔCVP for predicting | CVP-mean – CVP-end | ≥ 2 mmHg was 0.709. With a high diagnostic specificity, using ΔCVP&lt;3 to detect | CVP-mean – CVP-end | lower than 2mmHg (consistent measurement) resulted in a sensitivity of 22.37% and a specificity of 93.06%. Using ΔCVP&gt;8 to detect | CVP-mean – CVP-end | &gt;8 mmHg (inconsistent measurement) resulted in a sensitivity of 31.94% and a specificity of 91.32%.</p></div><div><h3>Conclusions</h3><p>Conclusions CVP-end and CVP-mean have statistical discrepancies in specific clinical scenarios. ΔCVP during the respiratory period is related to the variation of the two CVP methods. A high ΔCVP indicates a poor agreement between these two methods, whereas a low ΔCVP indicates a good agreement between these two methods.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 2","pages":"Pages 117-124"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9860033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Constipation and a Reduction in Lower Limb Muscle Strength in Preoperative Patients with Thoracic Spinal Tumors 胸腰椎肿瘤患者术前便秘与下肢肌力下降的关系
Q2 Medicine Pub Date : 2023-06-01 DOI: 10.24920/004154
Yong Liu, Si-Yuan Yao, Xi Zhou, Shu-Zhong Liu, Yan-Yan Bian

Objective

To investigate the clinical symptoms experienced by patients with thoracic spinal tumors and verify the associated symptoms that are predictive of a decline in muscle strength in the lower limbs.

Methods

A single-center, retrospective cross-sectional study was conducted on in-patients diagnosed with epidural thoracic spinal tumors between January 2011 and May 2021. The study involved a review of electronic medical records and radiographs and the collection of clinical data. The differences in clinical manifestations between patients with constipation and those without constipation were analyzed. Binary logistic regression analyses were performed to identify risk factors associated with a decline in muscle strength in the lower limbs.

Results

A total of 227 patients were enrolled, including 131 patients with constipation and 96 without constipation. The constipation group had a significantly higher proportion of patients who experienced difficulty walking or paralysis compared to those without constipation prior to surgery (83.2% vs. 17.7%, χ2 = 99.035, p < 0.001). Constipation (OR = 9.522, 95%CI: 4.150-21.849, p < 0.001) and urinary retention (OR = 14.490, 95%CI: 4.543–46.213, p < 0.001) were independent risk factors for muscle strength decline in the lower limbs.

Conclusions

The study observed that patients with thoracic spinal tumors who experienced constipation symptoms had a higher incidence of lower limb weakness. Moreover, the analysis revealed that constipation and urinary retention were independent risk factors associated with a preoperative decline in muscle strength of lower limbs.

目的探讨胸椎肿瘤患者的临床症状,并验证预测下肢肌力下降的相关症状。方法对2011年1月至2021年5月期间诊断为硬膜外胸椎肿瘤的住院患者进行单中心回顾性横断面研究。该研究涉及对电子医疗记录和射线照片的审查以及临床数据的收集。分析便秘患者和无便秘患者临床表现的差异。进行二元逻辑回归分析,以确定与下肢肌肉力量下降相关的风险因素。结果共纳入227例患者,其中便秘131例,无便秘96例。与手术前没有便秘的患者相比,便秘组出现行走困难或瘫痪的患者比例明显更高(83.2%对17.7%,χ2=99.035,p<;0.001)下肢力量下降。结论研究观察到,有便秘症状的胸椎肿瘤患者下肢无力的发生率较高。此外,分析显示,便秘和尿潴留是与术前下肢肌力下降相关的独立危险因素。
{"title":"Association Between Constipation and a Reduction in Lower Limb Muscle Strength in Preoperative Patients with Thoracic Spinal Tumors","authors":"Yong Liu,&nbsp;Si-Yuan Yao,&nbsp;Xi Zhou,&nbsp;Shu-Zhong Liu,&nbsp;Yan-Yan Bian","doi":"10.24920/004154","DOIUrl":"10.24920/004154","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the clinical symptoms experienced by patients with thoracic spinal tumors and verify the associated symptoms that are predictive of a decline in muscle strength in the lower limbs.</p></div><div><h3>Methods</h3><p>A single-center, retrospective cross-sectional study was conducted on in-patients diagnosed with epidural thoracic spinal tumors between January 2011 and May 2021. The study involved a review of electronic medical records and radiographs and the collection of clinical data. The differences in clinical manifestations between patients with constipation and those without constipation were analyzed. Binary logistic regression analyses were performed to identify risk factors associated with a decline in muscle strength in the lower limbs.</p></div><div><h3>Results</h3><p>A total of 227 patients were enrolled, including 131 patients with constipation and 96 without constipation. The constipation group had a significantly higher proportion of patients who experienced difficulty walking or paralysis compared to those without constipation prior to surgery (83.2% <em>vs.</em> 17.7%, <em>χ</em><sup>2</sup> <em>=</em> 99.035, <em>p</em> &lt; 0.001). Constipation (<em>OR =</em> 9.522, 95%<em>CI</em>: 4.150-21.849, <em>p</em> &lt; 0.001) and urinary retention (<em>OR =</em> 14.490, 95%<em>CI</em>: 4.543–46.213, <em>p</em> &lt; 0.001) were independent risk factors for muscle strength decline in the lower limbs.</p></div><div><h3>Conclusions</h3><p>The study observed that patients with thoracic spinal tumors who experienced constipation symptoms had a higher incidence of lower limb weakness. Moreover, the analysis revealed that constipation and urinary retention were independent risk factors associated with a preoperative decline in muscle strength of lower limbs.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 2","pages":"Pages 109-116"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9851475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dupilumab for Treatment of Food-Dependent, Exercise-Induced Anaphylaxis: Report of One Case Dupilumab治疗食物依赖性、运动性过敏:一例报告
Q2 Medicine Pub Date : 2023-06-01 DOI: 10.24920/004208
Li-Ping Zhu , Rui Tang , Qing Wang, Hong Li

Food-dependent, exercise-induced anaphylaxis (FDEIA) is a potentially life-threatening disorder that often occurs with exercise, and patients typically have eaten a specific food within hours before disease onset. This disease is exceedingly rare, with a prevalence of 0.02%. No well-recognized prevention or treatment strategy has been available for FDEIA except avoiding triggers strictly. Here we report an 11-year-old boy with a history of recurrent anaphylaxis of unknown etiology more than 10 times within two years. As the anaphylactic symptoms had not been controlled after traditional treatments, the patient was given subcutaneous injection of dupilumab seven times within 33 weeks. During dupilumab treatments, the patient was exposed to culprit mushrooms plus exercises at least twice a month but without notable anaphylaxis. Thus, dupilumab may improve the allergic reactions in FDEIA patients.

食物依赖性运动诱发过敏反应(FDEIA)是一种潜在的危及生命的疾病,经常发生在运动中,患者通常在发病前数小时内吃过特定的食物。这种疾病极为罕见,患病率为0.02%。除了严格避免触发因素外,FDEIA没有公认的预防或治疗策略。在此,我们报告一名11岁男孩,他在两年内有10次以上病因不明的复发性过敏反应史。由于传统治疗后过敏症状没有得到控制,患者在33周内皮下注射了7次杜匹单抗。在dupilumab治疗期间,患者每月至少两次接触罪魁祸首蘑菇和运动,但没有明显的过敏反应。因此,dupilumab可以改善FDEIA患者的过敏反应。
{"title":"Dupilumab for Treatment of Food-Dependent, Exercise-Induced Anaphylaxis: Report of One Case","authors":"Li-Ping Zhu ,&nbsp;Rui Tang ,&nbsp;Qing Wang,&nbsp;Hong Li","doi":"10.24920/004208","DOIUrl":"10.24920/004208","url":null,"abstract":"<div><p>Food-dependent, exercise-induced anaphylaxis (FDEIA) is a potentially life-threatening disorder that often occurs with exercise, and patients typically have eaten a specific food within hours before disease onset. This disease is exceedingly rare, with a prevalence of 0.02%. No well-recognized prevention or treatment strategy has been available for FDEIA except avoiding triggers strictly. Here we report an 11-year-old boy with a history of recurrent anaphylaxis of unknown etiology more than 10 times within two years. As the anaphylactic symptoms had not been controlled after traditional treatments, the patient was given subcutaneous injection of dupilumab seven times within 33 weeks. During dupilumab treatments, the patient was exposed to culprit mushrooms plus exercises at least twice a month but without notable anaphylaxis. Thus, dupilumab may improve the allergic reactions in FDEIA patients.</p></div>","PeriodicalId":35615,"journal":{"name":"Chinese Medical Sciences Journal","volume":"38 2","pages":"Pages 159-162"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9858131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Chinese Medical Sciences Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1